CD-P-PH/PHO - Database and publications
melclass database
Recommendations on the classification of medicines and their supply conditions: available in the Melclass database
Evidence-based classification reviews
- Evidence-based reviews of medicines belonging to the ATC group D04A and Naloxone (2022)
- Evidence-based reviews of medicines belonging to the ATC groups S01GA and S01GX (2022)
- Evidence-based reviews of medicines belonging to the ATC group R05DA and Doxylamine (2021)
- Evidence-based reviews of medicines belonging to the ATC group R05DB (2021)
- Evidence-based reviews of medicines belonging to the ATC group D07A (2019)
- Evidence-based reviews of medicines belonging to the ATC group N02B (2019)
- Evidence-based reviews of medicines belonging to the ATC group R01 (2019)
- Evidence-based reviews of medicines with various ATC codes (2019)
- Evidence-based reviews of medicines belonging to the ATC group G01AF and Promethazine (2017)
- Evidence-based reviews of medicines belonging to the ATC groups A02BA and A02BC (2016)
Survey reports
- Survey report “National requirements for non-prescription medicines and reclassification of medicines” 2024
- Survey report “New trends as regards the supply modes of medicines” 2020
online access
If you wish to know the classification of a medicine in a particular country or the CD-P-PH/PHO’s recommendation on the prescription status and related supply conditions of a medicine, you can do so via the
Additional information
